Harpagoside
Harpagoside can be obtained by Harpagophytum procumbens, which has anti-inflammatory, anti-cancer, protective activity, and efficacy. Harpagoside has an inhibitory effect on COX-1 and COX-2 active, and suppresses NO production. Harpagoside inhibits HepG2 cell lipid polysaccharide, which is a protein that is expressed horizontally and selectively, and has anti-inflammatory and latent pain effects. Harpagoside has the ability to protect the body, and has a degenerative effect on the β-oxidation (Aβ) [1][2][3].
Product Specifications
CAS Number
19210-12-9
UNSPSC
12352005
Hazard Statement
H302
Target
COX; NO Synthase
Type
Natural Products
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Cancer
Assay Protocol
https://www.medchemexpress.com/harpagoside.html
Concentration
10mM
Purity
99.88
Solubility
DMSO : 62.5 mg/mL (ultrasonic)
Smiles
O[C@H]1[C@H](O)[C@@H](O)[C@]([H])(O[C@@H]2OC=C[C@]3(O)[C@@]2([H])[C@@](C)(OC(/C=C/C4=CC=CC=C4)=O)C[C@H]3O)O[C@@H]1CO
Molecular Formula
C24H30O11
Molecular Weight
494.49
Precautions
H302
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Isoform
COX-1; COX-2
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD117 / c-Kit (Marker for Gastrointestinal Stromal Tumors) (KIT/2673), CF647 conjugate, 0.1mg/mL
